Cavadis | developing diagnostic tests for cardiovascular disease

ROUTE CONTACT

HOME

PRODUCTS

RESEARCH & DEVELOPMENT

Novel biomarkers
for cardiovascular
risk assessment

We develop
diagnostic tests for
cardiovascular diseases

Biomarkers
predictive for
cardiovascular events

Your partner in
cardiovascular biomarker
discovery and validation

About Cavadis

Cavadis

Cavadis is a Dutch biomedical company active in the field of cardiovascular risk assessment. We develop prognostic tests to identify patients at risk of cardiovascular disease. The company identified several novel biomarkers predictive for cardiovascular events. It is our goal is to develop clinically meaningful risk stratification tools that will help personalize treatment and achieve better patient outcomes.
read more

Medical Need

The search for new biomarkers in the field of cardiovascular prevention is intensifying. Traditional risk factors such as overweight, cholesterol and high blood pressure are insufficient to adequately assess cardiovascular risk, especially for secondary events. There is an urgent need for novel biomarkers that can distinguish between patients at high or low risk for cardiovascular events.
read more

At a glance

The Team

The Cavadis team is an ambitious group of professionals with strong medical, scientific and commercial backgrounds.
read more

Pipeline

Our products under development

The Cavadis pipeline contains a series of novel biomarkers in various phases of validation. Several individual markers or multi-marker panels have been selected for developing prognostic tests for a variety of cardiovascular indications, including heart attack (MI), stroke, and peripheral artery disease (PAD).
read more